EDGAR Filing Documents for 0001193125-22-058562

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-22-058562

Filing Date

2022-03-01

Accepted

2022-02-28 18:02:41

Documents

Effectiveness Date

2022-03-01

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d52521ds8.htm	S-8	46094
2	EX-5.1	d52521dex51.htm	EX-5.1	11123
3	EX-23.1	d52521dex231.htm	EX-23.1	1894
4	EX-FILING FEES	d52521dexfilingfees.htm	EX-FILING FEES	20296
5	GRAPHIC	g52521g0225212850793.jpg	GRAPHIC	4260
	Complete submission text file	0001193125-22-058562.txt		86504

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263113 | Film No.: 22692299
SIC: 2836 Biological Products, (No Diagnostic Substances)